Icotrokinra: Understanding Its Effects in Healthy Volunteers

We are exploring how long icotrokinra stays in the body and how it works when taken as different tablet types and with various foods. This research aims to improve our understanding of the medication's behavior.

Safety phase (I)Infectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Janssen Pharmaceutica
Clinical Pharmacology Unit
Merksem, Belgium
SGS Belgium
SGS Clinical Pharmacology Unit
Wilrijk, Belgium
Sponsor: Janssen Cilag International
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.